Skip to main content

Table 2 Summary of systemic adjuvant treatment recommendations by modality and expertise

From: Computational prediction of multidisciplinary team decision-making for adjuvant breast cancer drug therapies: a machine learning approach

Adjuvant treatment

Recommendation

Modality

Expertise

Recorded

Recommended

Not Recommended

For discussion

  

N

(%)

N

(%)

N

(%)

N

(%)

Chemotherapy

MDT

975

(92)

342

(35)

393

(40)

240

(25)

ESMO

1065

(100)

321

(30)

701

(66)

43

(4)

NCCN

1065

(100)

489

(46)

80

(8)

496

(47)

Endocrine therapy

MDT

1002

(94)

794

(79)

86

(9)

122

(2)

ESMO

1065

(100)

927

(87)

138

(13)

0

(0)

NCCN

1065

(100)

874

(82)

143

(13)

48

(5)

Trastuzumab

MDT

456

(43)

86

(19)

363

(80)

7

(2)

ESMO

1065

(100)

142

(13)

923

(87)

0

(0)

NCCN

1065

(100)

125

(12)

929

(87)

11

(1)

  1. MDT multidisciplinary conference, ESMO European society for medical oncology, NCCN national comprehensive cancer network